Lubiprostone in constipation: clinical evidence and place in therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lubiprostone in constipation: clinical evidence and place in therapy
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume 6, Issue 2, Pages 40-50
Publisher
SAGE Publications
Online
2015-02-06
DOI
10.1177/2040622314567678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lubiprostone for treatment-resistant constipation associated with clozapine use
- (2014) J. M. Meyer et al. ACTA PSYCHIATRICA SCANDINAVICA
- Differentiation between human ClC-2 and CFTR Cl− channels with pharmacological agents
- (2014) John Cuppoletti et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
- (2014) Byron Cryer et al. PAIN MEDICINE
- Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia
- (2013) Eric S. Schiffhauer et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota
- (2013) Mark W. Musch et al. DIGESTIVE DISEASES AND SCIENCES
- PTH-195 Lubiprostone Treatment Improves Constipation and Related Symptoms in Patients Refractory to other Constipation Therapies
- (2013) R M Panas et al. GUT
- Lubiprostone induced ischemic colitis
- (2013) Muhammed Sherid WORLD JOURNAL OF GASTROENTEROLOGY
- Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP)-mediated Pathway
- (2013) Walter W Chan et al. Journal of Neurogastroenterology and Motility
- Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
- (2012) W. D. Chey et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
- (2012) William D Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
- (2012) Satish Rao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Lubiprostone stimulates small intestinal mucin release
- (2012) Robert C De Lisle BMC GASTROENTEROLOGY
- Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl− Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl− Currents
- (2012) John Cuppoletti et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Lubiprostone Targets Prostanoid Signaling and Promotes Ion Transporter Trafficking, Mucus Exocytosis, and Contractility
- (2012) Robert L. Jakab et al. DIGESTIVE DISEASES AND SCIENCES
- May the Truth Be with You: Lubiprostone as EP Receptor Agonist/ClC-2 Internalizing “Inhibitor”
- (2012) Yasutada Akiba et al. DIGESTIVE DISEASES AND SCIENCES
- Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors
- (2012) John Cuppoletti et al. BMC Pharmacology & Toxicology
- Lubiprostone for Constipation in Adults with Cystic Fibrosis: A Pilot Study
- (2011) Catherine E O'Brien et al. ANNALS OF PHARMACOTHERAPY
- Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
- (2011) Anthony J. Lembo et al. DIGESTIVE DISEASES AND SCIENCES
- Lubiprostone for the treatment of opioid-induced bowel dysfunction
- (2011) Banny S Wong et al. EXPERT OPINION ON PHARMACOTHERAPY
- Severe Defects in Absorptive Ion Transport in Distal Colons of Mice That Lack ClC-2 Channels
- (2011) Marcelo A. Catalán et al. GASTROENTEROLOGY
- Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study
- (2011) S. Fukudo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation
- (2010) J. F. JOHANSON et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies
- (2010) M. Camilleri et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Use of the Chloride Channel Activator Lubiprostone for Constipation in Adults with Cystic Fibrosis: A Case Series
- (2010) Catherine E O'Brien et al. ANNALS OF PHARMACOTHERAPY
- Lubiprostone targets prostanoid EP4 receptors in ovine airways
- (2010) AW Cuthbert BRITISH JOURNAL OF PHARMACOLOGY
- Lubiprostone Reverses the Inhibitory Action of Morphine on Mucosal Secretion in Human Small Intestine
- (2010) Xiaohong Sun et al. DIGESTIVE DISEASES AND SCIENCES
- Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
- (2009) Misa Mizumori et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
- (2009) Charles F. Barish et al. DIGESTIVE DISEASES AND SCIENCES
- Activation of Intestinal Cl− Secretion by Lubiprostone Requires the Cystic Fibrosis Transmembrane Conductance Regulator
- (2009) Marcel J.C. Bijvelds et al. GASTROENTEROLOGY
- Long-Acting Opioids and Short-Acting Opioids: Appropriate Use in Chronic Pain Management
- (2009) Perry G. Fine et al. PAIN MEDICINE
- Lubiprostone: Clinical applications beyond constipation
- (2009) Shailendra Kapoor WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
- (2008) D. A. DROSSMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A synthetic prostone activates apical chloride channels in A6 epithelial cells
- (2008) Hui Fang Bao et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology
- (2008) Thomas J. Jentsch CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- A population-based study of irritable bowel syndrome in a non-Western population
- (2008) n. husain et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation
- (2007) John F Johanson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now